Skip to main content
WHO - Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control)

WHO - Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control)

  • Contact us
    • General Contacts
    • Immunization Devices Contacts
    • In Vitro Diagnostics
    • Vaccines Contacts
    • Medicines Contacts
    • Vector control
    • Inspection Services
  • Glossary & Acronyms
  • FAQ

Main menu 4 levels

  • PQT Home
  • Product Streams
    • Immunization Devices
      • Menu Column 1
        • About Immunization Devices Prequalification
        • What We Do
        • Documents A-Z
        • WHO Catalogue of Prequalified Immunization Devices
      • Menu Column 2
        • Procuring Prequalified Products
        • Standards Overview
        • Prequalification Procedures & Fees
          • Evaluation process
          • Retroactivity and grandfathering
        • Product Testing Support for Manufacturers
        • Laboratory Accreditation for Product Testing
      • Menu Column 3
        • Post-prequalification Procedures & Fees
        • Post-market Monitoring
          • Enhancing post-market monitoring
        • Guidance Documents
          • Prequalification guidance for manufacturers
          • Performance specifications
          • Verification protocols
          • Target product profiles
          • Standard operating procedures
          • Supporting information for users
        • Market Information
    • In Vitro Diagnostics
      • Menu Column 1
        • About In Vitro Diagnostic & Male Circumcision Device Prequalification
        • What We Do
        • Documents A-Z
        • Prequalified In Vitro Diagnostics
        • Prequalified Male Circumcision Devices
        • In Vitro Diagnostics Under Assessment
      • Menu Column 2
        • IVDs Eligible for WHO Prequalification
        • MCDs Eligible for Prequalification
        • MCDs Under Assessment
        • Prequalification Procedures & Fees: IVDs
        • Prequalification Procedures & Fees: MCDs
        • Post-prequalification Procedures & Fees: Prequalified IVDs
          • Annual reporting
          • Changes to prequalified IVDs
          • Post-market surveillance
        • Post-prequalification Procedures: Prequalified MCDs
      • Menu Column 3
        • Prequalification Reports
        • Collaborative Procedure for Accelerated Registration
        • Guidance Documents
          • Prequalification guidance
          • Technical Specifications Series
          • Technical Guidance Series
          • Sample product dossiers
        • Support to Manufacturers
          • Technical advice
          • Pre-submission meetings
          • Specialized technical assistance
        • Emergency Use Listing Procedure
        • Expert Review Panel for Diagnostics
        • Market Information
    • Medicines
      • Menu Column 1
        • About Medicines Prequalification
        • What We Do
        • Documents A-Z
        • Prequalification Pipeline
          • FPPs under assessment
        • Prequalified Lists
          • Finished pharmaceutical products
          • Active pharmaceutical ingredients
          • Medicines quality control laboratories
        • FPPs and APIs Eligible for Prequalification ("EOIs")
      • Menu Column 2
        • Prequalification Procedures & Fees: FPPs, APIs & QCLs
          • Medicines / FPPs
          • Active pharmaceutical ingredients
          • Medicines quality control laboratories
        • Post-prequalification Procedures & Fees: APIs, FPPs, QCLs
          • Amendments to APIMFs
          • Variations to FPPs
          • Requalification of FPPs
          • Quality monitoring
          • Monitoring QCL performance
        • Prequalification Reports
          • WHO Public Assessment Reports
          • WHO Public Inspection Reports
        • Collaborative Procedures for Accelerated Registration
          • Accelerated registration of prequalified FPPs
          • Accelerated registration of FPPs approved by SRAs
      • Menu Column 3
        • Guidance Documents
          • WHO Technical Report Series
          • WHO medicines prequalification guidance
          • International Pharmacopoeia
        • Pilot Prequalification of Biotherapeutic Products
        • Support to Manufacturers, CROs and QCLs
          • Technical advice
          • Pre-submission meetings
          • Specialized technical assistance
          • Capacity building for QCLs
        • Risk Assessment
        • Market Information
    • Vaccines
      • Menu Column 1
        • About Vaccines Prequalification
        • What We Do
        • Documents A-Z
        • List of Prequalified Vaccines
          • Prequalified vaccines
      • Menu Column 2
        • Vaccines Eligible for WHO Prequalification
        • Prequalification Procedures & Fees
          • Assessment
          • Fees for prequalification
        • Post-prequalification Procedures
          • Variation classification
          • Prequalified vaccine annual report (PQVAR)
          • Reassessment
          • Targeted testing
          • Complaints handling by WHO
      • Menu Column 3
        • Guidance Documents
          • WHO Technical Report Series
          • WHO position papers
          • SAGE reports
          • Biological reference preparations
          • Vaccine information by disease category
        • Prequalification Reports
          • WHO Public Assessment Reports
          • WHO Public Inspection Reports
        • Emergency Use Listing Procedure
        • Market Information
        • Risk Assessment - Snake Antivenom
          • Snake antivenom assessment procedure
          • Call for Applications
          • List of Product Assessment Outcomes
          • TAG-SAIL
          • Guidelines
    • Vector Control Products
      • Menu Column 1
        • About Vector Control Products Prequalification
        • What We Do
        • Documents A-Z
      • Menu Column 2
        • List of Prequalified Vector Control Products
        • Prequalification Pipeline
        • Prequalification Procedures & Fees
          • Determination of pathway
          • Pre-submission
          • Dossier preparation
          • Submitting applications
          • Screening & assessment
        • Post-prequalification Procedures & Fees
      • Menu Column 3
        • Prequalification Reports
          • WHO Public Inspection Reports
          • ITN Product Review Report
        • WHO Specifications for Pesticides
        • Guidance Documents
    • Inspection Services
      • Menu Column 1
        • About Inspection Services
        • What We Do
      • Menu Column 2
        • Documents A-Z
        • Inspection Services Procedures
        • WHO Public Inspection Reports (WHOPIRs)
      • Menu Column 3
        • Notice of Concern
        • International Collaboration
  • Events
  • News
  • About

Inspection Services

Latest News

  • 30 May 2023:

    WHO list of SARS-CoV-2 IVDs currently under assessment for Emergency Use Listing updated
  • 30 May 2023:

    Revised web page for Active Pharmaceutical Ingredients (APIs) published
  • 30 May 2023:

    New WHO Public Inspection Report (WHOPIR) published
  • 25 May 2023:

    2nd Invitation to Manufacturers of therapeutics against Ebola Virus Disease to submit an Expression of Interest (EOI) published
  • 24 May 2023:

    Workshop with UNDP to enhance understanding the prequalification process
see all


Summary Report of Preliminary Inspection Findings - Open Joint-Stock Company Pharmstandard - Ufa Vitamin Plant Ufa, Republic of Bashkortostan, Russia

news 23 June 2021
Related Documents

Summary Report of Preliminary Inspection Findings - Open Joint-Stock Company Pharmstandard - Ufa Vitamin Plant, Ufa - (31 May - 04 June 2021), Ufa, Russia

Featured News

First long-acting insulin analogues prequalified

5 May 2023 - WHO Prequalification Unit (PQT) added the below new products to its prequalified list: BT-DM005 - Insulin glargine - 100 U/mL - Solution for injection in a vial - Sanofi-Aventis Deutschland...
see more
WHO - Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control)
  • Site Map
    • Key Resources
    • Events
    • News
    • FAQ
  • WHO links
    • World Health Organization (WHO)
    • WHO Regulation and Prequalification
    • WHO Medicines Quality Assurance
    • WHO Essential Medicines and Health Products
    • WHO Medical Devices
    • WHO Global Malaria Programme
  • Contact us
    • General Contacts
    • Immunization Devices Contacts
    • In Vitro Diagnostics
    • Vaccines Contacts
    • Medicines Contacts
    • Vector control
    • Inspection Services
  • Glossary & Acronyms
  • FAQ

Stay in touch

  • Facebook
  • RSS
  • Privacy
  • Email Scams
© 2023 WHO Prequalification